Insiders who reported open-market trades in the last 12 months at the companies Richard Daniell files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Richard D. Francis - $31.26M in TEVA purchases and sales in the last 12 months
Roberto Mignone - $22.82M in TEVA purchases and sales in the last 12 months
Eliyahu Sharon Kalif - $20.73M in TEVA purchases and sales in the last 12 months
Mark Sabag - $13.15M in TEVA purchases and sales in the last 12 months
Eric A. Hughes - $4.17M in TEVA purchases and sales in the last 12 months
Christine Fox - $2.75M in TEVA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Richard Daniell is a corporate insider, tracked as EVP, Europe Commercial of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Richard Daniell last file a Form 4?
The most recent primary Form 4 on record is dated 7 May 2026, one of 6 filings going back to 2025.
Has Richard Daniell been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($12.08M) across all tracked filings.
Richard Daniell is EVP, Europe Commercial of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA). 6 SEC Form 4 filings on record going back to 2025, most recently on 7 May 2026. Most recent open-market trade: sold $1.06M of TEVA on 7 May 2026. Lifetime open-market sales: $12.08M.
Recent transactions
15
The latest 15 SEC Form 4 transactions reported by Richard Daniell.
InsiderAlpha's records for Richard Daniell go back to 2025: 6 primary Form 4 filings, an average of 3.0 per year. 17 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
